Literature DB >> 15868646

Successful rituximab treatment of severe pemphigus vulgaris resistant to multiple immunosuppressants.

Joerg Wenzel, Ralf Bauer, Thomas Bieber, Thomas Tüting.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15868646     DOI： 10.1080/00015550410024111

Source DB:  PubMed          Journal:  Acta Derm Venereol        ISSN： 0001-5555            Impact factor:   4.437


× No keyword cloud information.
  3 in total

1.  Rituximab in the treatment of pemphigus vulgaris.

Authors:  Labib R Zakka; Shawn S Shetty; A Razzaque Ahmed
Journal:  Dermatol Ther (Heidelb)       Date:  2012-11-15

2.  Effectiveness and side effects of anti-CD20 therapy for autoantibody-mediated blistering skin diseases: A comprehensive survey of 71 consecutive patients from the Initial use to 2007.

Authors:  Jennifer D Peterson; Lawrence S Chan
Journal:  Ther Clin Risk Manag       Date:  2009-03-26       Impact factor: 2.423

Review 3.  Management of Pemphigus Vulgaris.

Authors:  Mimansa Cholera; Nita Chainani-Wu
Journal:  Adv Ther       Date:  2016-06-10       Impact factor: 3.845
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.